The market is speculating on long-term growth prospects because the multiple that we apply is on the short term, the next year or the year after that the multiple comes up on that number.
Molbio Diagnostics shares rally 9% as Jefferies initiates ‘high conviction top pick’ call for recently listed stock. Why is it bullish?
Molbio Diagnostics shares jumped after Jefferies initiated coverage with a Buy rating and named it a high-conviction top pick. The brokerage set a Rs 1,600
September 30, 2026